Single course of high dose dexamethasone is more effective than conventional prednisolone therapy in the treatment of primary newly diagnosed immune thrombocytopenia
Open Access
- 28 August 2012
- journal article
- Published by Springer Science and Business Media LLC in DARU Journal of Pharmaceutical Sciences
- Vol. 20 (1), 7
- https://doi.org/10.1186/2008-2231-20-7
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- High-dose dexamethasone shifts the balance of stimulatory and inhibitory Fcγ receptors on monocytes in patients with primary immune thrombocytopeniaBlood, 2011
- High-dose dexamethasone regulates interleukin-18 and interleukin-18 binding protein in idiopathic thrombocytopenic purpuraHaematologica, 2009
- Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working groupBlood, 2009
- Therapy with high-dose dexamethasone (HD-DXM) in previously untreated patients affected by idiopathic thrombocytopenic purpura: a GIMEMA experienceBlood, 2006
- An open‐label, unit dose‐finding study of AMG 531, a novel thrombopoiesis‐stimulating peptibody, in patients with immune thrombocytopenic purpuraBritish Journal of Haematology, 2006
- Management of Adult Idiopathic Thrombocytopenic PurpuraAnnual Review of Medicine, 2005
- Treatment of Immune Thrombocytopenic Purpura in ChildrenPediatric Drugs, 2005
- Initial Treatment of Immune Thrombocytopenic Purpura with High-Dose DexamethasoneThe New England Journal of Medicine, 2003
- Advances in the diagnosis of idiopathic thrombocytopenic purpuraSeminars in Hematology, 2000
- Response of Resistant Idiopathic Thrombocytopenic Purpura to Pulsed High-Dose Dexamethasone TherapyThe New England Journal of Medicine, 1994